Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
EBIATLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Aethlon Medical (AEMD) Shares Outstanding (2016 - 2025)

Aethlon Medical filings provide 15 years of Shares Outstanding readings, the most recent being $258531.0 for Q1 2025.

  • On a quarterly basis, Shares Outstanding rose 686.45% to $258531.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $258531.0, a 686.45% increase, with the full-year FY2025 number at $258531.0, up 686.45% from a year prior.
  • Shares Outstanding hit $258531.0 in Q1 2025 for Aethlon Medical, up from $174838.0 in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $15.4 million in Q4 2021 to a low of $32873.0 in Q1 2024.
  • Median Shares Outstanding over the past 5 years was $2.3 million (2022), compared with a mean of $4.4 million.
  • Biggest five-year swings in Shares Outstanding: tumbled 93.27% in 2024 and later soared 686.45% in 2025.
  • Aethlon Medical's Shares Outstanding stood at $15.4 million in 2021, then tumbled by 85.09% to $2.3 million in 2022, then rose by 13.04% to $2.6 million in 2023, then tumbled by 93.27% to $174838.0 in 2024, then surged by 47.87% to $258531.0 in 2025.
  • The last three reported values for Shares Outstanding were $258531.0 (Q1 2025), $174838.0 (Q4 2024), and $174529.0 (Q3 2024) per Business Quant data.